Ketamine
- Generic Name
- Ketamine
- Brand Names
- Ketalar
- Drug Type
- Small Molecule
- Chemical Formula
- C13H16ClNO
- CAS Number
- 6740-88-1
- Unique Ingredient Identifier
- 690G0D6V8H
- Background
Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic eff...
- Indication
Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior oth...
- Associated Conditions
- -
- Associated Therapies
- General Anesthesia, Induction and Maintenance of General Anesthesia
Magnesium and Cramping
- Conditions
- Interventions
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- William Beaumont Hospitals
- Target Recruit Count
- 150
- Registration Number
- NCT06745388
- Locations
- 🇺🇸
Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, United States
Pro-Epileptic Effects of IV Ketamine
- Conditions
- Interventions
- First Posted Date
- 2024-12-19
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Haseki Training and Research Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06741930
- Locations
- 🇹🇷
Haseki Training and Research Hospital, Istanbul, Turkey
Intravenous Ketamine for Treatment-Resistant Depression
- Conditions
- Interventions
- First Posted Date
- 2024-10-31
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 30
- Registration Number
- NCT06668571
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Comparing Ketamine and Fentanyl in Pediatric Tonsillectomy: Pain Control and Emergence Delirium Outcomes (KVFPT)
- Conditions
- Interventions
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Medipol University
- Target Recruit Count
- 59
- Registration Number
- NCT06630364
- Locations
- 🇹🇷
Medipol Mega University Hospital, Istanbul, Bagcılar, Turkey
FMRI of Patients Receiving IV Ketamine for Treatment Resistant Bipolar Depression
- Conditions
- Interventions
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Brian Barnett
- Target Recruit Count
- 20
- Registration Number
- NCT06620042
- Locations
- 🇺🇸
Cleveland Clinic Lutheran Hospital, Ohio City, Ohio, United States
The Impact of Preoperative Suggestion on Dreaming
- Conditions
- Interventions
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2024-09-24
- Lead Sponsor
- Wonkwang University Hospital
- Target Recruit Count
- 250
- Registration Number
- NCT06609538
- Locations
- 🇰🇷
WonwangUH, Iksan, Please Select, Korea, Republic of
Pain Palliation in Forearm Fractures in the Emergency Department
- Conditions
- Interventions
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Ankara Etlik City Hospital
- Target Recruit Count
- 78
- Registration Number
- NCT06588907
- Locations
- 🇹🇷
Ankara Etlik City Hospital, Ankara, Yenimahalle, Turkey
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
- Conditions
- Interventions
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 70
- Registration Number
- NCT06559826
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 46
- Registration Number
- NCT06545890
- Locations
- 🇪🇬
Abu Elresh Hospitals ( Cairo university ), Cairo, Egypt
🇪🇬Abu ElResh hospital, Cairo, Egypt
Ketamine Therapy for Methamphetamine Use Disorder & HIV
- Conditions
- Interventions
- First Posted Date
- 2024-08-05
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Nicky Mehtani, MD, MPH
- Target Recruit Count
- 12
- Registration Number
- NCT06538285
- Locations
- 🇺🇸
San Francisco Department of Public Health, San Francisco, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.